A Global Response to HIV Requires the Global Fund
The Global Fund to Fight AIDS, Tuberculosis and Malaria is among the world’s largest and most effective investors in global infectious disease eradication. In 2017, the Global Fund mobilized nearly $4 billion to support life-saving initiatives to fight HIV, tuberculosis (TB) and malaria in 104 countries. In addition to complimentary work with the President’s Emergency Plan for AIDS Relief (PEPFAR) to deliver quality HIV programs, the Global Fund operates programs in 51 additional countries, with a total population of 1.2 billion people.
Click here or the image to the right to download the infographic. .
|
 |
How the Global Fund Improves PEPFAR Investments
The President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF) work together in the world’s most highly burdened countries to provide life-saving antiretroviral drugs (ARVs) for HIV.
In 2017, the GF spent $886 million on ARVs in PEPFAR countries, and it is frequently the primary purchaser of ARVs for an entire country. In these areas, such as Malawi where HIV prevalence is 10% and the GF purchases nearly 100% of the ARVs, PEPFAR relies heavily on GF investments to reach its goals.
Click here or the image to the right to download the infographic. .
|
 |